Artificial intelligence (AI) and machine learning (ML) are being used to innovate drug development, particularly for cancer treatments. These advancements can make treatments faster, more cost-effective, and lead to more personalized and effective cancer therapies.
Insights & Events
Staying on top of beneficiaries – a practical and important end-of-life matter
September 24, 2024
In this blog, Shawn Smith, Sun Life's AVP of Group Claims, shares his short list of tips and reminders for HR professionals to refer to as they remind their employees to review and update their beneficiary designations.
The Final Countdown: The Potential Impacts of the 2024 Election
September 20, 2024
James Slotnick, Sun Life’s VP Government Relations & Sustainability, discusses potential impacts of the 2024 election for the Employee Benefits landscape with a focus on policy shifts, tax considerations and key states to look out for.